…
DocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
DocGo Inc operates mobile, on-site and in-home healthcare services in the United States, delivering urgent care, diagnostic and other non-emergency clinical services outside traditional settings. Long-term growth drivers include demographic ageing, payer and provider interest in lower-cost site-of-care alternatives and wider adoption of at-home care, which may benefit the company's addressable market. Investors may view exposure to the shift toward community-based care and operational scale as attractive.
Principal risks include reimbursement and regulatory uncertainty, intense competition from health systems and telehealth firms, and execution and profitability pressures while scaling operations.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Income before tax | 22.78M | 19.80M | -14.63M | -21.19M |
| Minority interest | -3.84M | -4.56M | 0.44M | 1.03M |
| Net income | 34.58M | 23.74M | -14.80M | -21.24M |
| Selling general administrative | 112.18M | 78.80M | 38.66M | 27.18M |
| Selling and marketing expenses | 4.76M | 4.76M | 0.75M | 1.37M |
| Gross profit | 154.72M | 109.75M | 31.35M | 13.19M |
| Reconciled depreciation | 10.57M | 7.07M | 5.51M | 4.18M |
| Ebit | 21.83M | 10.49M | -14.76M | -20.76M |
| Ebitda | 34.21M | 17.56M | -9.58M | -16.70M |
| Depreciation and amortization | 12.38M | 7.07M | 5.18M | 4.06M |
| Non operating income net other | -0.99M | - | - | - |
| Operating income | 21.83M | 10.49M | -14.76M | -20.76M |
| Other operating expenses | 418.68M | 303.36M | 108.85M | 69.06M |
| Interest expense | 0.76M | 763030.00M | 0.90M | 0.72M |
| Tax provision | -7.96M | 0.62M | 0.17M | 0.05M |
| Net interest income | 0.76M | -0.76M | -0.20M | -0.55M |
| Non recurring | 11.70M | 3.91M | - | - |
| Income tax expense | -7.96M | 0.62M | 0.17M | 0.05M |
| Total revenue | 440.52M | 318.72M | 94.09M | 48.30M |
| Total operating expenses | 132.89M | 94.39M | 46.10M | 33.95M |
| Cost of revenue | 285.79M | 208.97M | 62.74M | 35.11M |
| Total other income expense net | 0.95M | 9.31M | 0.13M | -0.43M |
| Net income from continuing ops | 30.74M | 19.18M | -14.80M | -21.24M |
| Net income applicable to common shares | 34.58M | 23.74M | -14.36M | -20.21M |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | 490.45M | 393.28M | 309.60M | 100.17M | 100.96M |
| Intangible assets | 37.68M | 22.97M | 10.68M | 10.67M | 9.97M |
| Other current assets | 17.50M | 6.27M | 2111656.00M | 1.15M | 1.24M |
| Total liab | 185.28M | 114.35M | 82.55M | 33.23M | 21.60M |
| Total stockholder equity | 300.79M | 273.23M | 219.58M | 55.00M | 68.47M |
| Other current liab | 22.14M | 72.85M | 0.74M | 0.05M | 5.12M |
| Common stock | 0.01M | 0.01M | 0.01M | - | - |
| Capital stock | 0.01M | 0.01M | 0.01M | 0.00M | 0.00M |
| Retained earnings | -21.39M | -28.97M | -63.56M | -87.30M | -72.94M |
| Other liab | - | - | 13.52M | - | - |
| Good will | 47.54M | 38.90M | 8.69M | 6.61M | 6.31M |
| Other assets | - | 20.36M | 7.38M | 3.36M | 5.13M |
| Cash | 59.29M | 157.34M | 175.54M | 32.42M | 47.74M |
| Total current liabilities | 170.12M | 100.16M | 57.88M | 23.50M | 9.73M |
| Current deferred revenue | 96.81M | - | 35.95M | 15.33M | - |
| Net debt | -12.79M | -137.42M | -159.03M | -18.53M | -32.20M |
| Short term debt | 31.34M | 5.72M | 5.36M | 4.16M | 3.67M |
| Short long term debt | 25.03M | 0.66M | 0.63M | 0.66M | 0.56M |
| Short long term debt total | 46.50M | 19.91M | 16.51M | 13.89M | 15.54M |
| Other stockholder equity | 320.69M | 301.45M | 283.16M | 142.35M | 141.66M |
| Property plant equipment | - | 21.26M | 26.24M | 21.10M | 20.41M |
| Total current assets | 338.87M | 271.08M | 256.03M | 58.42M | 59.14M |
| Long term investments | 0.55M | 0.60M | 0.59M | - | - |
| Net tangible assets | - | 211.36M | 200.22M | 37.71M | 52.20M |
| Short term investments | 553572.45M | - | - | - | - |
| Net receivables | 262.08M | 103.00M | 78.38M | 24.85M | 10.16M |
| Long term debt | 0.04M | 1.24M | 14.82M | 0.59M | 0.75M |
| Inventory | 0.00M | 4.48M | -2111653.89M | - | - |
| Accounts payable | 19.83M | 21.58M | 15.83M | 3.95M | 0.95M |
| Noncontrolling interest in consolidated entity | - | 5.70M | 7.48M | - | - |
| Accumulated other comprehensive income | 1.48M | 0.74M | -0.03M | -0.05M | -0.24M |
| Common stock total equity | - | 0.01M | 0.01M | - | - |
| Retained earnings total equity | - | -28.97M | -63.56M | - | - |
| Non currrent assets other | 15.50M | 10.40M | 7.38M | 3.36M | 5.13M |
| Deferred long term asset charges | - | 9.96M | - | - | - |
| Non current assets total | 151.58M | 122.20M | 53.57M | 41.75M | 41.82M |
| Capital lease obligations | 21.43M | 18.01M | 14.58M | 12.63M | 14.22M |
| Long term debt total | - | 1.24M | 14.82M | - | - |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Investments | -38.45M | -0.66M | -6.04M | -2.97M |
| Change to liabilities | -2.33M | 11.88M | 3.01M | -0.10M |
| Total cashflows from investing activities | -38.45M | -8.59M | -6.04M | -2.97M |
| Net borrowings | -0.97M | -2.82M | -2.28M | -3.20M |
| Total cash from financing activities | -6.18M | 155.21M | -0.81M | 56.34M |
| Change to operating activities | -8.40M | 17.31M | 9.54M | 2.15M |
| Net income | 30.74M | 19.18M | -14.80M | -21.24M |
| Change in cash | -15.00M | 144.65M | -17.31M | 38.91M |
| Begin period cash flow | 179.11M | 34.46M | 51.77M | 12.85M |
| End period cash flow | 164.11M | 179.11M | 34.46M | 51.77M |
| Total cash from operating activities | 28.87M | -1.95M | -10.65M | -14.21M |
| Issuance of capital stock | 0.00M | 178.10M | 0.00M | 49.04M |
| Depreciation | 10.57M | 7.07M | 5.51M | 4.18M |
| Other cashflows from investing activities | -35.25M | -0.05M | -0.05M | -0.05M |
| Dividends paid | - | 8.63M | - | - |
| Change to account receivables | -8.42M | -58.00M | -16.15M | -2.28M |
| Sale purchase of stock | -3.73M | -0.48M | - | - |
| Other cashflows from financing activities | -1980583.51M | -2.97M | 1.47M | 59.54M |
| Change to netincome | 2.10M | -3.96M | 1.80M | 2.05M |
| Capital expenditures | 5.50M | 6.66M | 6.32M | 3.80M |
| Change receivables | -8.42M | -58.00M | - | - |
| Cash flows other operating | -0.56M | -0.54M | - | - |
| Exchange rate changes | - | -0.02M | - | - |
| Cash and cash equivalents changes | -15.76M | 144.65M | - | - |
| Change in working capital | -13.18M | -28.80M | -3.61M | -0.22M |
| Stock based compensation | 8.05M | 1.38M | 0.69M | 0.46M |
| Other non cash items | 2.64M | -0.14M | -0.30M | 0.15M |
| Free cash flow | 23.37M | -8.60M | -16.97M | -18.01M |
Sector: Healthcare Industry: Medical Care Facilities
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| DCGO DocGo Inc |
0.01 5.49% |
0.26 | 15.80 | 13.04 | 0.54 | 1.13 | 0.52 | 10.38 |
| HCA HCA Healthcare, Inc. |
9.74 1.97% |
504.73 | 14.27 | 13.46 | 1.21 | 291.34 | 1.83 | 8.99 |
| THC Tenet Healthcare Corporation |
10.62 3.75% |
293.95 | 10.08 | 12.66 | 0.96 | 4.57 | 1.43 | 5.80 |
| FSNUY Fresenius SE & Co KGaA ADR |
0.27 1.86% |
14.79 | 16.87 | 9.44 | 0.42 | 0.78 | 0.79 | 5.37 |
| JDHIY JD Health International Inc |
0.29 5.59% |
5.57 | 62.50 | 35.97 | 0.30 | 2.32 | 0.16 | 3.90 |
DocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.
| Name | Title | Year Born |
|---|---|---|
| Mr. Stan Vashovsky | Co-Founder, Chairman & CEO | 1972 |
| Mr. Anthony Capone | Pres | 1987 |
| Mr. Andre Oberholzer CPA | Chief Financial Officer | 1958 |
| Mr. Ely D. Tendler | Gen. Counsel, Sec. & Director | 1968 |
| Mr. Lee Bienstock | Chief Operating Officer | 1984 |
| Mr. Stephen Sugrue | Chief Compliance Officer | 1972 |
| Mr. Ben Sherman | EVP of Corp. Devel. | NA |
| Ms. Rosemarie Milano | VP of HR | NA |
| Mr. Norman Rosenberg | Chief Financial Officer of Ambulnz Holdings, LLC | 1969 |
| Dr. Mark Merlin | Chief Medical Officer of Ambulnz Holdings, LLC | 1968 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.